Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, New Horizon Health's Enterprise Value is HK$6,345 Mil.
New Horizon Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil. Therefore, New Horizon Health's EV-to-EBIT ratio for today is 843.69.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, New Horizon Health's Enterprise Value is HK$6,345 Mil.
New Horizon Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil. Therefore, New Horizon Health's EV-to-EBITDA ratio for today is 843.69.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, New Horizon Health's Enterprise Value is HK$6,345 Mil.
New Horizon Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$1,502 Mil. Therefore, New Horizon Health's EV-to-Revenue ratio for today is 4.22.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
New Horizon Health (HKSE:06606) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
New Horizon Health's current Enterprise Value is HK$6,345 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
New Horizon Health's current Enterprise Value is HK$6,345 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil.
New Horizon Health's current Enterprise Value is HK$6,345 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$1,502 Mil.
New Horizon Health's current Enterprise Value is HK$6,345 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-574 Mil.
New Horizon Health's current Enterprise Value is HK$6,345 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-694 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Horizon Health Enterprise Value Related Terms
New Horizon Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for New Horizon Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06606 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, New Horizon Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Horizon Health Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where New Horizon Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
New Horizon Health's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$6,345 Mil mean?
New Horizon Health (HKSE:06606) has a Enterprise Value of HK$6,345 Mil as of Jul. 23, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on New Horizon Health and its competitors.
Is New Horizon Health's Enterprise Value too high?
New Horizon Health's current Enterprise Value is HK$6,345 Mil. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's Enterprise Value compare to ABT and SYK?
New Horizon Health's Enterprise Value of HK$6,345 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on New Horizon Health and its competitors. New Horizon Health's current Enterprise Value is HK$6,345 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (HKSE:06606) has a current Enterprise Value of HK$6,345 Mil. The current Enterprise Value is HK$6,345 Mil. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For New Horizon Health (HKSE:06606), the current Enterprise Value is HK$6,345 Mil as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score
Get the complete analysis for HKSE:06606
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06606 has been successfully added to your 
